Literature DB >> 6411175

Intranasal glucagon raises blood glucose concentrations in healthy volunteers.

A E Pontiroli, M Alberetto, G Pozza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411175      PMCID: PMC1548756          DOI: 10.1136/bmj.287.6390.462-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Comparison of plasma levels of luteinizing hormone releasing hormone in men after intravenous or intranasal administration.

Authors:  G Fink; G Gennser; P Liedholm; J Thorell; J Mulder
Journal:  J Endocrinol       Date:  1974-11       Impact factor: 4.286

2.  Absorption of insulin from the human small intestine.

Authors:  C W Crane; G R Luntz
Journal:  Diabetes       Date:  1968-10       Impact factor: 9.461

3.  Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

Authors:  A E Pontiroli; M Alberetto; A Secchi; G Dossi; I Bosi; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
  3 in total
  15 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon.

Authors:  G Slama; C Alamowitch; N Desplanque; M Letanoux; P Zirinis
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

3.  Letter to the Editor: Intranasal Glucagon for Hypoglycemia.

Authors:  Antonio E Pontiroli
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

Review 4.  Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective.

Authors:  A E Pontiroli; A Calderara; G Pozza
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

5.  Intranasal calcitonin and plasma calcium concentrations in normal subjects.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

6.  Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun

Review 7.  Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.

Authors:  Antonio E Pontiroli
Journal:  J Diabetes Sci Technol       Date:  2014-11-10

8.  Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.

Authors:  Johannes Pöhlmann; Beth D Mitchell; Sanjay Bajpai; Beatrice Osumili; William J Valentine
Journal:  J Diabetes Sci Technol       Date:  2019-01-30

9.  Retinal laser photocoagulation in diabetic patients causes prolactin, growth hormone and cortisol release.

Authors:  A E Pontiroli; G Baio; P Maffi; U Menchini; R Brancato; G Pozza
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

10.  Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients.

Authors:  A E Pontiroli; A Calderara; M G Perfetti; S R Bareggi
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.